NEGTEC

NEGTEC is a South Korean biotechnology company specializing in advanced cell isolation and purification technologies for the development of next-generation cell therapies. The company's core platform utilizes a proprietary negative selection technology to isolate specific cell populations, such as T cells and stem cells, with high purity and viability without the use of magnetic beads or harsh chemicals. This approach is designed to minimize cell stress and maintain the natural functional characteristics of the isolated cells, which is critical for the efficacy of downstream therapeutic applications. NEGTEC's solutions target the growing market for CAR-T, TCR-T, and regenerative medicine, providing tools that streamline manufacturing processes and improve the quality of cellular starting materials.